StockClub

USRM

USRMU.S. Stem Cell, Inc.$ --
U.S. Stem Cell, Inc.

U.S. Stem Cell, Inc.

USRM

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2022FY2022 Q4
Revenue
0M USD
YoY -15.3%
Operating Income
-0M USD
YoY -3.2%
Net Income
-1M USD
YoY +11.6%
EPS
-0$
YoY +35.7%

Revenue

$82,049
FY2021 Q1$84,380
$84,380
Q1
FY2021 Q2$119,822
$119,822
Q2
FY2021 Q3$177,156
$177,156
Q3
FY2021 Q4$200,749
$200,749
Q4
FY2022 Q1$23,310
$23,310
Q1
FY2022 Q2$47,828
$47,828
Q2
FY2022 Q3$62,075
$62,075
Q3
FY2022 Q4$82,049
$82,049
Q4
Actual
$-118,700 (-59.1%)

Net Income

$-2.9M
FY2021 Q1$-979,756
$-979,756
Q1
FY2021 Q2$-2M
$-2M
Q2
FY2021 Q3$-2.6M
$-2.6M
Q3
FY2021 Q4$-3.3M
$-3.3M
Q4
FY2022 Q1$-1.2M
$-1.2M
Q1
FY2022 Q2$-1.7M
$-1.7M
Q2
FY2022 Q3$-2.3M
$-2.3M
Q3
FY2022 Q4$-2.9M
$-2.9M
Q4
Actual
+$429,473 (+13.1%)

Surprise History

Actual RevenueAnalyst Estimate
FY2017
Actual:$5.5M
FY2017
$5.5M
FY2018
Actual:$6.7M
FY2018
$6.7M
FY2019
Actual:$3.1M
FY2019
$3.1M
FY2020
Actual:$277,087
FY2020
$277,087
FY2021
Actual:$200,749
FY2021
$200,749
FY2022
Actual:$82,049
FY2022
$82,049

Analyst Estimates

No forecast data